Lysozyme gene treatment in testosterone induced benign prostate hyperplasia rat model and comparasion of its' effectiveness with botulinum toxin injection.

about

Lysozyme gene treatment in testosterone induced benign prostate hyperplasia rat model and comparasion of its' effectiveness with botulinum toxin injection.

Item

http://www.wikidata.org/entity/Q47103636

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Lysozyme gene treatment in tes ...... ith botulinum toxin injection.

@en

Lysozyme gene treatment in tes ...... ith botulinum toxin injection.

@nl

type

Item

label

Lysozyme gene treatment in tes ...... ith botulinum toxin injection.

@en

Lysozyme gene treatment in tes ...... ith botulinum toxin injection.

@nl

prefLabel

Lysozyme gene treatment in tes ...... ith botulinum toxin injection.

@en

Lysozyme gene treatment in tes ...... ith botulinum toxin injection.

@nl

P1476

Lysozyme gene treatment in tes ...... with botulinum toxin injection

@en

P2093

Alim Koşar

http://www.w3.org/2001/XMLSchema#string

Osman Ergün

http://www.w3.org/2001/XMLSchema#string

Pinar Aslan Koşar

http://www.w3.org/2001/XMLSchema#string

İbrahim Onaran

http://www.w3.org/2001/XMLSchema#string

P2860

Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses

Proliferative lesions in the male reproductive system of F344 rats and B6C3F1 mice: incidence and classification.

Effects of 100 and 300 units of onabotulinum toxin A on lower urinary tract symptoms of benign prostatic hyperplasia: a phase II randomized clinical trial

A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.

Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature.

A signaling network in phenylephrine-induced benign prostatic hyperplasia.

The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.

Direct toxic effects of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture.

Botox-induced prostatic involution.

Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.

P304

1167-1175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S1677-5538.IBJU.2016.0677

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hakan Darici

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28727388

http://www.w3.org/2001/XMLSchema#string

P932

5734082

http://www.w3.org/2001/XMLSchema#string